- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The impact of CBP expression in estrogen receptor-positive breast cancer ; volume:13 ; number:1 ; day:7 ; month:4 ; year:2021 ; pages:1-18 ; date:12.2021
Clinical epigenetics ; 13, Heft 1 (7.4.2021), 1-18, 12.2021
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-021-01060-2
- URN
-
urn:nbn:de:101:1-2021052908214227471253
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ramadan, Wafaa S.
- Talaat, Iman M.
- Hachim, Mahmood Y.
- Lischka, Annette
- Gemoll, Timo
- El-Awady, Raafat
- SpringerLink (Online service)
Other Objects (12)
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers